A cornerstone of pharmaceutical manufacturing, the process of contamination control ensures that products meet the highest standards of safety, efficacy and quality. With the pharma industry becoming ever more reliant on overseas manufacturing sites, it has become increasingly hard to oversee the integrity of medication at all points along the supply chain and ensure that all regulatory requirements are met.
The new Contamination Control Zone, premiering at CPHI Milan this October, will provide attendees with insights into cutting-edge solutions, domestic suppliers, and strategies to address these critical issues. In this piece, we’ll explore the importance of pharmaceutical contamination control, the challenges posed by local oversight of overseas manufacturing, and how domestic, quality-focused suppliers can help the industry overcome these hurdles.



